| abstract |
The present invention relates to novel co-crystal forms of compounds of formula (I): The coformer molecules are selected from the group consisting of glycolic acid, salicylic acid, capric acid (capric acid), gentisic acid (2,5-dihydroxybenzoic acid), glutaric acid, vanillic acid (4-hydroxy-3-methyl oxybenzoic acid), succinic acid, malonic acid or maltol (3-hydroxy-2-methyl-4-pyrone); and processes for their preparation; pharmaceutical compositions containing such co-crystals; the Use of a co-crystaloid in the manufacture of a medicament for the prevention of arterial thrombotic complications in patients with coronary artery disease, cerebrovascular disease or peripheral vascular disease; Co-crystals are used to treat such diseases in humans or animals. |